Combination Therapies For Exudative AMD.

A conference paper about the use of combination approaches in the management of age-related macular degeneration is presented. It mentions the various treatments such as verteporfin photodynamic therapy and inhibitors of vascular endothelial growth factor (VEGF) like pegaptanib, ranibizumab and bevacizumab. It illustrates the improved outcomes brought by ranibizumab and bevacizumab which led to the increase use of these agents.